NCT03469999View on ClinicalTrials.gov

Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 12, 2018

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Cerebral Palsy
Interventions
DRUG

Dysport Injectable Product

Selected dose of medication will be determined by affected muscle(s), severity of spasticity, and the patient's body weight. We will follow the recommended total Dysport dose of 10-15 units/kg per limb, not to exceed 15 units/kg for unilateral lower limb, 30 units/kg for bilateral lower limb, or a total of 1000 units, whichever is lower in a given session.

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03469999 - Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral Palsy | Biotech Hunter | Biotech Hunter